Recent developments in pharmacologic prophylaxis of atrial fibrillation in patients undergoing surgical revascularization

Cardiovascular and Hematological Agents in Medicinal Chemistry

Volumn 7, Issue 2, 2009, Pages 137-146

  Rostagno, Carlo ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Antiarrhythmic drugs; Atrial fibrillation; Statins; Surgical revascularization

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTIINFLAMMATORY AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESMOLOL; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM SULFATE; METOPROLOL; METOPROLOL SUCCINATE; OMEGA 3 FATTY ACID; PLACEBO; SOTALOL;

ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; COST OF ILLNESS; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; HEART ATRIUM FIBRILLATION; HEART FIBRILLATION; HEART MUSCLE REVASCULARIZATION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; LOADING DRUG DOSE; NAUSEA; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROPHYLAXIS; STROKE; SURGICAL TECHNIQUE; TORSADE DES POINTES; UNSPECIFIED SIDE EFFECT; ANIMAL; CHEMOPROPHYLAXIS; CORONARY ARTERY BYPASS GRAFT; ECONOMICS; METHODOLOGY; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; STATISTICS;

ANIMALS; ATRIAL FIBRILLATION; CHEMOPREVENTION; CORONARY ARTERY BYPASS; GUIDELINES AS TOPIC; HUMANS; RISK FACTORS;

EID: 67650617955     PISSN: 18715257     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152509787847074     Document Type: Article

References (99)

1. Hravnak, M.; Hoffman, L.A.; Saul, M.I.; Zullo, T.G.; Whitman, G.R.; Griffith, B.P. Predictors and impact of atrial fibrillation after isolated coronary artery bypass grafting. Crit. Care Med., 2002, 30(2), 330.
2. Hogue, C.W., Jr.; Hyder, M.L. Atrial fibrillation after cardiac operations: risks; mechanisms; and treatment. Ann. Thorac. Surg., 2000, 69, 300.
3. Leitch, J.W.; Thomson, D.; Baird, D.K.; Harris, P.J. The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg., 1990, 100, 342.
4. Fuller, J.A.; Adams, G.G.; Buxton, B. Atrial fibrillation after coronary artery bypass grafting: is it a disorder of the elderly? J. Thorac. Cardiovasc. Surg., 1989, 97, 821.
5. Fleisher, L.A.; Bass, E.B.; McKeown, P. Methodological approach american college of chest physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest, 2005, 128, 17S-23S.
6. Lathinen, J.; Biancari, F.; Salmela, E.; Mosorin, M.; Satte, J.; Rainio, P.; Rimpilanen, J.; Lepojervi, M.; Juvonen, T. Postoperative atrial fibrillation a major cause of stroke after on pump coronary artery bypass surgery. Ann. Thorac. Surg., 2004, 77, 241.
7. Roach, G.W.; Kanchuger, M.; Mangano, C.M. Adverse cerebral outcomes after coronary artery bypass surgery. N. Engl. J. Med., 1996, 335, 1857.
8. Yousif, H.; Davies, G.; Oakley, C.M. Peri-operative supraventricular arrhythmias in coronary bypass surgery. Int. J. Cardiol., 1990, 26, 313.
9. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation. A Report of the American College of Cardiology American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation, 2006, 114, 257.
10. Auer, J.; Berent, R.; Weber, T.; Ng, C.K.; Lassnig, E.; Lamm, G.; Eber, B. Antiarrhythmic therapy on prevention of postoperative atrial fibrillation in patients after heart surgery. Curr. Med. Chem. Cardiovasc. Hematol. Agents 2004, 2, 29.
11. Baker, W.L.; White, C.M. Post-cardiothoracic surgery atrial fibrillation: a review of preventive strategies. Ann. Pharmacother., 2007, 41, 587.
12. Blanchard, L.; Collard, C.D. Non-antiarrhythmic agents for prevention of postoperative atrial fibrillation: role of statins. Curr. Opin. Anaesthesiol., 2007, 20, 53.
13. Maisel, W.H.; Rawn, J.D.; Stevenson, W.G. Atrial fibrillation after cardiac surgery. Ann. Intern. Med., 2001, 135, 1061.
14. Villareal, R.P.; Harihararan, R.; Liu, B.C.; Kar, B.; Lee, V.V; Elayda, M.; Lopez, J.A.; Rasekh, A.; Wilson, J.M.; Massumi, A. Postoperative atrial fibrillation and mortality after coronary artery by pass surgery. J. Am. Coll. Cardiol., 2004, 43, 472.
15. Ommen, S.R.; Odell, J.A.; Stanton, M.S. Atrial arrhythmias after cardiothoracic surgery. N. Engl. J. Med., 1997, 336, 1429.
16. Andrews, T.C.; Reimold, S.C.; Berlin, J.A.; Antman, E.M. Prevention of supraventricular arrhythmias after coronary artery bypass surgery: a meta-analysis of randomized control trials. Circulation, 1991, 84, III236.
17. Hogue, C.W., Jr.; Creswell, L.L.; Gutterman, D.D.; Fleisher, L.A. Epidemiology; mechanisms; and risks: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest, 2005, 128, 9S.
18. Hogue, C.W., Jr.; Hyder, M.L. Atrial fibrillation after cardiac operations: risks, mechanisms, and treatment. Ann. Thorac. Surg., 2000, 69, 300.
19. Caretta, Q.; Mercanti, C.A.; De Nardo, D.; Chiaritoti, F.; Scibilia, G.; Reale, E.; Marino, B. Ventricular conduction defects and atrial fibrillation after coronary artery bypass grafting: multivariate analysis of preoperative; intraoperative and postoperative variables. Eur. Heart J., 1991, 12, 1107.
20. Matangi, M.F.; Neutze, J.M.; Graham, K.J.; Hill, D.G.; Ken, A.R.; Barrat-Boyes, B.G. Arrhythmia prophylaxis after aorta-coronary bypass: the effect of mini dose propranolol. J. Thorac. Cardiovasc. Surg., 1985, 89, 439.
21. Mills, S.A.; Poole, G.V., Jr.; Breyer, R.H.; Holliday, R.H.; Lavender, S.W., Jr.; Blanton, K.R.; Hudspeth, A.S.; Johnston, F.R.; Codell, A.R. Digoxin and propranolol in the prophylaxis of dysrhythmias after coronary artery bypass grafting. Circulation, 1983, 68, II-222.
22. Lahey, S.J.; Campos, C.T.; Jennings, B.; Pavolov, P.; Stokes, T.; Levitsky, S. Hospital readmission after cardiac surgery: Does "fast track" cardiac surgery result in cost saving or cost shifting? Circulation, 1998, 98(Suppl.), II-35.
23. Aranki, S.F.; Shaw, D.P.; Adams, D.H.; Rizzo, R.J.; Couper, G.S.; VanderVliet, M.; Collins, J.J., Jr.; Cohn, L.H.; Burst, H.R. Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources. Circulation, 1996, 94, 390.
24. Mathew, J.P.; Parks, R.; Savino, J.S.; Friedman, A.S.; Koch, C.; Mangano, D.T.; Browner, W.S. Atrial fibrillation following coronary artery bypass graft surgery: predictors; outcomes; and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. JAMA, 1996, 276(4), 300.
25. Creswell, L.L.; Schuessler, R.B.; Rosenbloom, M.; Cox, J.L. Hazards of postoperative atrial arrhythmias. Ann. Thorac. Surg., 1993, 36, 253.
26. Davies, M.J.; Pomerance, A. Pathology of atrial fibrillation in man. Br. Heart J., 1972, 34, 520.
27. Lie, J.T.; Hammond, P.I. Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients of 90 to 105 years old. Mayo Clin. Proc., 1988, 63, 552.
28. Smith, P.K.; Buhrman, W.C.; Levett, J.M.; Ferguson, T.B., Jr.; Holman, W.L.; Cox, J.L. Supraventricular conduction abnormalities following cardiac operations: a complication of inadequate atrial preservation. J. Thorac. Cadiovasc. Surg., 1983, 85, 105.
29. Mullen, J.C.; Khan, N.; Weisel, R.D.; Christakis, G.T.; Teok, K.H.; Madonik, M.; Mickle, D.A.; Ivanov, J. Atrial activity during cardioplegia and postoperative arrhythmias. J. Thorac. Cardiovasc. Surg., 1987, 94, 558.
30. Almassi, G.H.; Schowalter, T.; Nicolosi, A.C.; Aggarwal, A.; Moritz, T.E.; Henderson, W.G.; Tarazi, R.; Shroyer, A.L.; Sethi, G.K.; Grover, F.L.; Hammermeister, K.E. Atrial fibrillation after cardiac surgery: a major morbid event? Ann. Surg., 1997, 226(4), 501.
31. Zacharias, A.; Schwann, T.A.; Riordan, C.J.; Durham, S.J.; Shah, A.S.; Habib, R.H. Obesity and risk of new-onset atrial fibrillation after cardiac surgery. Circulation, 2005, 112, 3247.
32. Rastan, A.J.; Eckenstein, J.I.; Hentschel, B.; Funkat, A.K.; Gummer, J.F.; Doll, N.; Walther, T.; Falk, V.; Mohr, F.W. Emergency coronary artery bypass graft surgery for acute coronary sindrome beating heart versus conventional cardioplegic cardiac arrest strategies. Circulation, 2006, 114(Suppl. I), I-477.
33. Mathew, J.P.; Fontes, M.L.; Tudor, I.C.; Ramsay, J.; Duke, P.; Mazer, C.D.; Barash, P.G.; Hsu, P.H.; Mangano, D.T. Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA, 2004, 291(14), 1720.
34. Zaman, A.G.; Alamgir, F.; Richens, T.; Williams, R.; Rothman, M.T.; Mills, P.G. The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery. Heart, 1997, 77, 527.
35. Steinberg, J.S.; Zelenkofske, S.; Wong, S.C.; Gelerent, M.; Sciacca, R.; Menchavez, E. Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation, 1993, 88, 2618.
36. Lowe, J.E.; Hendry, P.J.; Hendrickson, S.C.; Wells, R. Intraoperative identification of cardiac patients at risk to develop postoperative atrial fibrillation. Ann. Surg., 1991, 213, 388.
37. Cox, J.L. A perspective on postoperative atrial fibrillation. Semin. Thorac. Cardiovasc. Surg., 1999, 11, 299.
38. Loubani, M.; Hickey, M.S.; Spyt, T.J.; Galinanes, M. Residual atrial fibrillation and clinical consequences following post operative supraventricular arrhythmias. Int. J. Cardiol., 2000, 74, 125.
39. Kowey, P.R.; Dalessando, D.A.; Herbertson, R.; Briggs, B.; Wertan, M.A.; Rials, S.J.; Filart, R.A.; Marinchack, R.A. Effectiveness of digitalis with or without acebutolol in preventing atrial arrhythmias after coronary artery surgery. Am. J. Cardiol., 1997, 79, 1114.
40. Taylor, G.J.; Mikell, F.L.; Moses, W.; Dove, J.T.; Kartholi, R.E.; Malik, S.A.; Markwell, S.J.; Korsmeyer, C.; Schneider, C.; Wellens, H.A. Determinants of hospital charges for coronary artery bypass surgery: the economic consequences of postoperative complications. Am. J. Cardiol., 1990, 65, 309.
41. Mauldin, P.D.; Weintraub, W.S.; Becker, E.R. Predicting hospital costs for first time coronary artery bypass grafting from preoperative and postoperative variables. Am. J. Cardiol., 1994, 74, 772.
42. Crystal, E.; Connolly, S.J.; Sleid, K.; Ginger, T.J.; Yusuf, S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation, 2002, 106, 75.
43. Daoud, E.G.; Strickberger, A.; Man, C.K.; Gogol, R.; Deeb, G.M.; Bolling, S.F.; Pagani, F.D.; Bitar, C.; Meissner, M.D.; Morady, F. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N. Engl. J. Med., 1997, 337, 1785.
44. Lee, S.H.; Chan, C.M.; Lu, M.J.; Lee, R.J.; Cheng, J.J.; Hung, C.R.; Chen, S.A. Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting. Ann. Thorac. Surg., 2000, 70, 157.
45. Sideris, D.A.; Toumanidis, S.T.; Tselepatiotis, E.; Kostopoulos, K.; Stringes, T.; Kitsou, T.; Moulopoulos, S.D. Atrial pressure and experimental atrial fibrillation. Pacing Clin. Electrophysiol., 1995, 18, 1679.
46. Vardas, P.E.; Vemmos, K.; Sideris, D.A.; Moulopoulos, S.D. Susceptibility of the right and left canine atria to fibrillation in hyperglycemia and hypoglycemia. J. Electrocardiol., 1993, 26, 147.
47. Wang, J.; Liu, L.; Feng, J.; Nattel, S. Regional and functional factors determining induction and maintenance of atrial fibrillationin dogs. Am. J. Physiol., 1996, 271, H148.
48. Skubas, N.J.; Barzilai, B.; Hogue, C.W., Jr. Atrial fibrillation after CABG surgery is unrelated to cardiac abnormalities detected by transesophageal echocardiography. Anesth. Analg., 2001, 93, 14.
49. Shore-Lesserson, L.; Moskowitz, D.; Hametz, C.; Andrews, D.; Yamada, T.; Vela-Cantas, F.; Hossain, S.; Bodian, C.; Lesson, R.J.; Konstadt, S.N. Use of intraoperative transesophageal echocardiography to predictatrial fibrillation after coronary artery bypass grafting. Anesthesiology, 2001, 95, 652.
50. Moe, G.K. A conceptual model of atrial fibrillation. J. Electrocardiol., 1968, 1, 145.
51. Ducceschi, V.; D'Andrea, A.; Liccardo, B.; Alfieri, A.; Sarubbi, B.; De Feo, M.; Santangelo, L.; Cotrufo, M. Perioperative clinical predictors of atrial fibrillation occurrence following coronary artery surgery. Eur. J. Cardiothorac. Surg., 1999, 16, 435.
52. Wu, T.J.; Ong, J.J.; Chang, C.M.; Doshi, R.N.; Yashima, M.; Huang, H.L.; Fishbein, M.C.; Ting, T.C.; Koragueurion, H.S.; Chen, P.S. Pulmonary veins and ligament of Marshall as sources of rapid activations in acanine model of sustained atrial fibrillation. Circulation, 2001, 103, 1157.
53. Aviles, R.J.; Martin, D.O.; Apperson-Hansen, C.; Houghtaling, P.L.; Rautaharju, P.; Kronmal, R.A.; Tracy, R.P.; Van Wagoner, D.R.; Psaty, B.M.; Lauer, M.S.; Chung, MK. Inflammation as a risk factor for atrial fibrillation. Circulation, 2003, 108, 3006.
54. Bruins, P.; te Velthuis, H.; Yazdanbakhsh, A.P.; Jansen, P.G.; van Hardevelt, F.W.; de Beaumont, E.M.; Wildevuur, C.R.; Eijsman, L.; Trouwborst, A.; Hack, C.E. Activation of the complement system during and after cardiopulmonary bypass surgery: post surgery activation involves C-reactive protein and is associated with post-operative arrhythmia. Circulation, 1997, 96, 3542.
55. Wang, G.K.; Wang, S.Y. Modifications of human cardiac sodium channel gating by UVA light. J. Membr. Biol., 2002, 189, 153.
56. Proebstle, T.; Mitrovics, M.; Schneider, M.; Hombach, V.; Rudel, R. Recombinant interleukin-2 acts like a class I antiarrhythmic drug on human cardiac sodium channels. Eur. J. Physiol., 1995, 429, 462.
57. Fernandez-Cobo, M.; Gingalewski, C.; Drujan, D.; De Maio, A. Down regulation of connexin 43 gene expression in rat heart during inflammation: the role of tumour necrosis factor. Cytokine, 1999, 11, 216.
58. Yosuke Ishii.; Schuessler, R.B.; Gaynor, S.L.; Yamada, K.; Fu, A.S.; Boineau, J.P.; Damiano, R.P., Jr. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation, 2005, 111, 2881.
59. Place, D.G.; Peragallo, R.A.; Carroll, J.; Cusimano, R.J.; Chery, D.C. Postoperative atrial fibrillation: a comparison of off-pump coronary artery bypass surgery and conventional coronary artery bypass surgery. J. Cardiothor. Vasc. Anesth., 2002, 16, 144.
60. Stamou, S.C.; Dangas, G.; Hill, P.C.; Pfister, A.J.; Dullum, M.K.; Boyce, S.W.; Bafi, A.S.; Garcia, J.M.; Corso, P.J. Atrial fibrillation after beating heart surgery. Am. J. Cardiol., 2000, 86, 64.
61. Cohn, W.E.; Sirois, C.A.; Johnson, R.G. Atrial fibrillation after minimally invasive coronary artery bypass grafting: a retrospective, matched study. J. Thorac. Cardiovasc. Surg., 1999, 117, 298.
62. Ascione, R.; Caputo, M.; Calori,G.; Lloyd, C.T.; Underwood, M.J.; Angelici, G.D. Predictors of atrial fibrillation after conventional and beating heart coronary surgery: a prospective, randomized study. Circulation, 2000, 102, 1530.
63. Van Dijk, D.; Nierich, A.P.; Jansen, E.W.L.; Nathal, H.M.; Suyker, W.J.; Diephuis, J.C.; Van Boven, D.; Borst, C.; Buskens, E.; Grobbee, D.E.; Robles de Medina, E.O.; de Jaggere, P.P. Octopus Study Group. Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study. Circulation, 2001, 104, 1761.
64. Buffolo, E.; de Andrade, J.C.S.; Branco, J.N.; Teles, C.A.; Aguiar, L.F.; Gomes, W.J. Coronary artery bypass grafting without cardiopulmonary bypass. Ann. Thorac. Surg., 1996, 61, 63.
65. Siebert, J.; Anisimowicz, L.; Lango, R.; Rogowski, J.; Pawlaczyk, R.; Brzezinski, M.; Beta, S.; Narkiewicz, M. Atrial fibrillation after coronary artery bypass grafting: does the type of procedure influence the early postoperative incidence? Eur. J. Cardiothorac. Surg., 2001, 19, 455.
66. Siebert, J.; Lewicki,; M..odnicki, M.; Rogowski, J.; Lango, R.; Anisimowicz, L.; Narkiewicz, M. Atrial fibrillation after conventional and off-pump coronary artery bypass grafting: two opposite trends in timing of atrial fibrillation occurrence? Med. Sci. Monit., 2003, 9, 137.
67. Creswell, L.L.; Alexander, J.C.; Ferguson, B.; Lisbon, A.; Fleisher, L.A. Intraoperatvive interventions: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery. Chest, 2005, 128, 28S.
68. Bradley, D.; Creswell, L.L.; Hogue, C.W., Jr.; Epstein, A.E.; Prystowsky, E.N.; Daoud, E.G. Pharmacologic Prophylaxis: American College of Chest Physicians Guidelines forthe Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery. Chest 2005, 128(2 Suppl.), 39S-47S.
69. Mitchell, L.B.; Exner, D.V.; Wyse, D.G.; Connolly, C.J.; Prystai, G.D.; Bayes, A.J.; Kidd, W.T.; Kieser, T.; Burgess, J.J.; Ferland, A.; MacAdams, C.L; Maitland, A. Prophylactic oral amiodarone for the prevention of arrhythmias that begin early efter revascularization, valve replacement, or repair PAPABEAR: a randomized controlled trial. JAMA, 2005, 294, 3093.
70. Giri, S.; White, C.M.; Dunn, A.B.; Felton, K.; Freeman-Bosco, L.; Reddy, P.; Tsikouris, J.P.; Wilcox, H.A.; Kluger, J. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the atrial fibrillation suppression trial [AFIST]: a randomised placebo-controlled trial. Lancet, 2001, 357, 830.
71. Turk, T.; Ata, Y.; Vural, H.; Ozkan, H.; Yavuz, S.; Ozyazicioclu, A. Intravenous and oral amiodarone for the prevention of postoperative atrial fibrillation in patients undergoing of-pump coronary bypass. Heart Surg. Forum, 2007, 10, E299.
72. Cagli, K.; Ozeke, O.; Ergun, K.; Budak, B.; Demirtas, E.; Birincioglu, C.L.; Pac, M. Effect of low-dose amiodarone and magnesium combination on atrial fibrillation after coronary artery surgery. J. Card. Surg., 2006, 21(5), 458.
73. Gillespie, E.L.; Coleman, C.I.; Sander, S.; Kluger, J.; Gryskiewicz, K.A.; White, C.M. Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysis. Ann. Pharmacother., 2005, 39, 1409.
74. Aasbo, J.D.; Lawrence, A.T.; Krishnan, K.; Kim, M.H.; Trohman, R.G. Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis. Ann. Intern. Med., 2005, 143, 327.
75. Imren, Y.; Benson, A.A.; Zor, H.; Tasoglu, I.; Ereren, E.; Sinci, V.; Gokgoz, L.; Halit, V. Preoperative beta-blocker use reduces atrial fibrillation in off-pump coronary bypass surgery. ANZ J. Surg., 2007, 77, 429.
76. Johnsson, G.; Regardh, C.G.; Solvell, I. Combined pharmacokinetic and pharmacodynamic studies in man of the adrenergic β1-receptor antagonist metoprolol. Acta Pharmacologica. et Toxicologica., 1975, 36(Suppl.), 31.
77. Halonen, J.; Hakala, T.; Auvinen, T.; Karjalainen, J.; Turpeinen, A.; Uusaro, A.; Halonen, P.; Hartikainen, J.; Hippelainen, M. Intravenous administration of metoprolol is more effective than oral administration in the prevention of atrial fibrillation after cardiac surgery. Circulation, 2006, 114(Suppl. I), I-1.
78. Balcetyte-Harris, N.; Tamis, J.E.; Homel, P.; Menchavez, E.; Steinberg, J.S. Randomized study of early intravenous esmolol in preventing post-CABG atrial fibrillation in high risk patients identified by signalaveraged ECG: results of a pilot study. Ann. Noninvasive Electrocardiol., 2002, 7, 86.
79. Mooss, A.N.; Wurdeman, R.L.; Sugimoto, J.T.; Packard, K.A.; Hilleman, D.E.; Lenz, T.L.; Rovang, K.S.; Arcidi, J.M.; Mohiuddin, S.M. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the reduction in postoperative cardiovascular arrhythmic events [REDUCE] trial. Am. Heart J., 2004, 148, 641.
80. Auer, J.; Weber, T.; Berent, R.; Puschmann, R.; Hartl, P.; Ng, C.K.; Schwarz, C.; Lehner, E.; Strasser, U.; Lassnig, E.; Lamm, G.; Eber, B. Study of prevention of postoperative atrial fibrillation. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation [SPPAF], a randomized, placebo-controlled trial. Am. Heart J., 2004, 147, 636.
81. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI - prevezione trial. Gruppo Italiano per lo studio della Sopravvivenza nell'infarto miocardico. Lancet, 1999, 354, 447.
82. Calo, L.; Bianconi, L.; Colivicchi, F.; Lamberti, F.; Loricchio, ML.; de Ruvo, E.; Meo, A.; Pandozi, C.; Staibano, M.; Santini, M. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J. Am. Coll. Cardiol., 2005, 45, 1723.
83. Nurozler, F.; Tokgozoglu, L.; Pasaoglu, I.; Boke, E.; Ersoy, U.; Borez, N.Y. Atrial fibrillation after coronary artery bypass surgery: predictors and the role of MgSO4 replacement. J. Card. Surg., 1996, 11, 421.
84. Fanning, W.J.; Thomas, C.S., Jr.; Roach, A.; Tomichek, R.; Alford, W.C.; Stoney W.S., Jr. Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting. Ann. Thorac. Surg., 1991, 52, 529.
85. Toraman, F.; Karabulut, E.H.; Alhan, H.C.; Dagdalen, S.; Tarcan, S. Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting. Ann. Thorac. Surg., 2001, 72, 1256.
86. Watchell, K.; Letho, M.; Gerdts, E.; Olsen, M.H.; Horvestam, B.; Dahlof, B.; Ibsen, H.; Iulius, S.; Kjedsen, S.E.; Lindholm, L.H.; Nieminen, M.S.; Devereux R.B. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan for End Point Reduction in Hypertension (LIFE) Study. J. Am. Coll. Cardiol., 2005, 45, 712.
87. Madrid, A.H.; Bueno, M.G.; Robollo, J.M.G. Use of irbesartan to maintain sinus rhythm in patients with long-lastin persistent atrial fibrillation. Circulation, 2002, 106, 331.
88. Healey, J.S.; Barandchuck, A.; Crystal, E.; Morillo, C.A.; Garfinkle, M.; Yusuf, S.; Connolly, S.J. Prevention of atrial fibrillation with angiotensin converting enzyme inhibitors and angitensin receptor blockers: a metaanalysis. J. Am. Coll. Cardiol., 2005, 45, 1832.
89. Fogari, R.; Mugellini, A.; Destro, M.; Corradi, L.; Zoppi, A.; Fagari, E.; Rinaldi, A. Losartan and prevention of atrial fibrillation recurrences in hypertensive patients. Cardiovasc. Pharmacol., 2006, 47, 56.
90. Coleman, C.I.; Makanji, S.; Kluger, J.; White, C.M. Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation. Ann. Pharmacother., 2007, 41, 433.
91. Halonen, J.; Halonen, P.; Jarvinen, O.; Taskinen, P.; Auvinen, T.; Tarkka, M.; Hippelainen, M.; Juvonen,T.; Hartikainen, J.; Hakala, T. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JAMA, 2007, 297, 1562.
92. Chung, M.K.; Martin, D.O.; Sprecher, D.; Warni, O.; Kanderian, A.; Carnes, C.A.; Bauer, J.A.; Tchou, P.J., Niebauer, M.J., Natale, A.; Van Wagoner, D.R. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation, 2001, 104, 2886.
93. Bonetti, P.O.; Lerman, L.O.; Napoli, C.; Lerman, A. Statin effects beyond lipid lowering: are they clinical relevant? Eur. Heart J., 2003, 24, 225.
94. Brull, D.J.; Sanders, D.; Rumley, A.; Lowe, D.G.; Humphries, S.E.; Montgomery, H.E. Statin therapy and the acute inflammatory response after coronary artery bypass grafting. Am. J. Cardiol., 2001, 88, 431.
95. Kumagai, K.; Nakashima, H.; Saku, K. The HMG CoA-reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc. Res., 2004, 62, 105.
96. Dotani, M.I.; Elnicki, D.M.; Jain, A.C.; Gibson, C.M. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am. J. Cardiol., 2000, 86, 1128.
97. Ozaydin, M.; Dogan, A.; Varol, E.; Kapan, S.; Tuzun, N.; Peker, O.; Aslan, S.M.; Altinbas, A.; Ocal, A.; Ibrisim, E. Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology, 2007, 107, 117.
98. Marín, F.; Pascual, D.A.; Roldán, V.; Arribas, J.M.; Ahumada, M.; Tornel, P.L.; Oliver, C.; Gómez-Plana, J.; Lip,G.Y.; Valdés, M. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am. J. Cardiol., 2006, 97, 55.
99. Patti, G.; Chello, M.; Caldura, D.; Pasceri, V.; D'Ambrosio, A.; Covino, E.; Di Sciascio, G. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery. Results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysirhythmias After cardiac surgery). Circulation, 2006, 114, 1455.